Table II.
Number of drugs per patient | Before IAT (n=18) | IAT (n=18) | ||
---|---|---|---|---|
n | Treatment | n | Treatment | |
0 | 7 | – | 0 | – |
1 | 6 | (1×BB) | 11 | (5×BB) |
(1×CCB) | (2×CCB) | |||
(4×ACE-I) | (4×ACE-I) | |||
2 | 3 | (2×ACE-I+D) | 4 | (2×BB+D) |
(1×CCB+D) | (1×ACE-I+D) | |||
(1×CCB+D) | ||||
3 | 2 | (1×CCB+ACE-I+D) | 1 | (1×CCB+ACE-I+D) |
(1×BB+CCB+D) | ||||
4 | 0 | 2 | (2×BB+CCB+ACE-I+D) |
BB – β-blocker, CCB – calcium channel blocker, ACE-I – inhibitor of angiotensin-converting enzyme, D – thiazide diuretic